Kingworld Medicines Group Limited

Research Kingworld Medicines Group Limited (1110.HK) on Bullrun: market cap HKD 219.21M, P/E 18.5. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Ticker1110.HK
ExchangeHK
CountryChina
SectorHealthcare
IndustryPharmaceutical Retailers
CurrencyHKD
Market capHKD 219.21M
P/E18.5
Financial periodFY2025
RevenueCNY 917.34M
Revenue growth-13.5%
Net incomeCNY 11.28M
Free cash flowCNY 54.92M
Gross margin27.0%

Valuation Snapshot

latest market cap is HKD 219.21M; P/E is 18.5.

Peer valuation comparison

Latest P/E is 18.5x versus a Healthcare sector median of 21.69x (14.7% below).

Latest P/E is 18.5x versus a China median of 16.26x (13.8% above).

Five-year financial history

Year	Revenue	Net income	Free cash flow	Gross margin	Diluted EPS	Cash	Total debt	Equity
FY2025	CNY 917.34M	CNY 11.28M	CNY 54.92M	27.0%	0.02	CNY 264.41M	CNY 433.87M	CNY 617.70M
FY2024	CNY 1.06B	CNY 41.56M	CNY 94.73M	25.5%	0.07	CNY 235.30M	CNY 402.44M	CNY 639.79M
FY2023	CNY 1.08B	CNY 38.10M	-CNY 63.25M	26.0%	0.06	CNY 173.68M	CNY 354.43M	CNY 619.03M
FY2022	CNY 957.70M	CNY 22.74M	CNY 93.04M	29.0%	0.04	CNY 242.16M	CNY 290.68M	CNY 615.58M

Valuation history

Year	Snapshot date	Market cap	P/E	Dividend yield	Annual dividend/share
2026	2026-10-18	HKD 219.21M	18.5	n/a	0.03

Dividend history

Latest trailing dividend snapshot: annual dividend/share 0.03 HKD.

Year	Dividends/share
FY2025	0.03 CNY
FY2024	0.03 CNY
FY2023	0.02 CNY
FY2022	0.02 CNY
FY2021	0.01 CNY

About Kingworld Medicines Group Limited

Kingworld Medicines Group Limited, an investment holding company, primarily engages in the distribution, manufacture, and sale of branded imported pharmaceutical and healthcare products.

Related stock research

China stocks China Healthcare stocks A-Z stock index

Other Healthcare stocks

Shanghai Pioneer Holding Ltd (1345.HK) Universal Health International Group Holding Limited (2211.HK) DaShenLin Pharmaceutical Group Co., Ltd. (603233.SS) Yifeng Pharmacy Chain Co., Ltd. (603939.SS) Fangzhou Inc. (6086.HK) New Ray Medicine International Holding Limited (6108.HK) JD Health International Inc. (6618.HK) YSB Inc. (9885.HK) Pomdoctor Ltd (POM) Ridgetech Inc (RDGT) Shandong Dong-Ee Jiao Co Ltd (000423.SZ) Livzon Pharmaceutical Group Inc (000513.SZ)

Frequently asked questions

What is Kingworld Medicines Group Limited's market cap?

Kingworld Medicines Group Limited's market capitalization is HKD 219.21M.

What is Kingworld Medicines Group Limited's P/E ratio?

Kingworld Medicines Group Limited's price-to-earnings (P/E) ratio is 18.5.

What does Kingworld Medicines Group Limited do?

Kingworld Medicines Group Limited, an investment holding company, primarily engages in the distribution, manufacture, and sale of branded imported pharmaceutical and healthcare products. The company offers products for relieving cough, alleviating phlegm, soothing asthma, enhancing respiratory system, aiding digestion, promoting intestinal health, activating blood circulation, relieving pain, combating flu, and other categories under the Nin Jiom Chuan Bei Pei Pa Koa, Taiko Seirogan, and Kingworld Imada Red Flower Oil brands.